Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

Market Cap	10.85B
Revenue (ttm)	6.79B
Net Income (ttm)	880.50M
Shares Out	178.70M
EPS (ttm)	4.92
PE Ratio	12.34
Forward PE	n/a
Dividend	2.80 (4.66%)
Ex-Dividend Date	Aug 1, 2024

Volume	210,849
Average Volume	162,022
Open	60.10
Previous Close	60.10
Day's Range	59.90 - 60.70
52-Week Range	59.90 - 79.40
Beta	0.12
RSI	36.56
Earnings Date	Mar 30, 2025

About TPE:1720

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2024, TPE:1720's revenue was 6.79 billion, an increase of 8.81% compared to the previous year's 6.24 billion. Earnings were 880.50 million, an increase of 5.46%.